Clark Capital Management Group, Inc. Jazz Pharmaceuticals PLC Transaction History

Clark Capital Management Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$95.68 - $121.88 $6.22 Million - $7.92 Million	-64,978 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$87.74 - $152.74 $9.71 Million - $16.9 Million	-110,664 Reduced 63.01%	64,978 $6.48 Million
Q4 2019 Jan 27, 2020	BUY	$117.65 - $153.73 $78,825 - $102,999	670 Added 0.38%	175,642 $26.2 Million
Q3 2019 Nov 06, 2019	SELL	$125.18 - $143.24 $8.22 Million - $9.41 Million	-65,699 Reduced 27.3%	174,972 $22.4 Million
Q2 2019 Jul 12, 2019	BUY	$125.55 - $144.48 $1.65 Million - $1.9 Million	13,138 Added 5.77%	240,671 $34.3 Million
Q1 2019 May 08, 2019	BUY	$121.81 - $142.95 $23.9 Million - $28 Million	195,951 Added 620.45%	227,533 $32.5 Million
Q4 2018 Feb 14, 2019	BUY	$115.94 - $166.74 $3.66 Million - $5.27 Million	31,582 New	31,582 $3.92 Million

516

57.8M

188K

110K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.54B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Clark Capital Management Group, Inc. with notifications on news.